Pacific Edge Ltd

PEB

Company Profile

  • Business description

    Pacific Edge Ltd is a New Zealand-based company involved in researching, developing, and commercialising new diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. It operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses internationally; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, which generates maximum revenue, New Zealand, and the Rest of the World.

  • Contact

    87 Saint David Street
    P.O. Box 56
    DunedinSTL9016
    NZL

    T: +64 35776733

    https://www.pacificedgedx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 March 2027

    Employees

    34

Stocks News & Analysis

stocks

Fair value lifts for toll road operator as Aussie fuel supply steadies

An Australian fuel shortage is becoming increasingly unlikely, a relief for ASX toll road operator.
stocks

These overvalued stocks are probably in your portfolio

Priced for perfection.
stocks

Wide moat stock exchange remains cheap

Aussie stock exchange remains materially undervalued despite growing cost concerns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,969.8023.200.26%
CAC 408,146.5936.75-0.45%
DAX 4025,003.04101.66-0.40%
Dow JONES (US)51,041.809.340.02%
FTSE 10010,338.9570.33-0.68%
HKSE25,398.18215.790.86%
NASDAQ27,159.86187.240.69%
Nikkei 22566,934.33604.830.91%
NZX 50 Index13,244.5538.440.29%
S&P 5007,614.3834.320.45%
S&P/ASX 2008,729.4019.400.22%
SSE Composite Index4,057.7410.83-0.27%

Market Movers